Yoonjoo Kim

12PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Liquid biopsiesMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 24, 2025
Modeling Drug and Radiation Resistance with Patient-Derived Organoids: Recent Progress, Unmet Needs, and Future Directions for Lung Cancer.

Dahye Lee, Yoonjoo Kim, Da Hyun Kang

|Jun 26, 2025
Spatial Transcriptomics in Lung Cancer and Pulmonary Diseases: A Comprehensive Review.

Da Hyun Kang, Yoonjoo Kim, Ji Hyeon Lee

|Jul 29, 2023
Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids.

Dongil Park, Dahye Lee, Yoonjoo Kim

|May 05, 2023
A patient with a lung adenosquamous carcinoma harboring a de novo T790M mutation and huge nonbacterial vegetative growths successfully treated with osimertinib: A case report.

So-Yun Kim, Ka Eun Kim, Yoonjoo Kim

|Dec 19, 2022
The Tri-iodothyronine (T3) Level Is a Prognostic Factor for Patients With Advanced NSCLC: Receiving Immune Checkpoint Inhibitors and Is Associated With Liver Metastasis.

Yoonjoo Kim, Jeong Suk Koh, Seong-Dae Woo

|Aug 19, 2022
Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis: A case report.

Yoonjoo Kim, Dongil Park, Song-Yi Choi

Pageof 2

Frequent Collaborators

8 joint publications

Chaeuk Chung

7 joint publications

Da Hyun Kang

6 joint publications

Dongil Park

3 joint publications

Jeong Eun Lee